J 2022

Hybridization Approach to Identify Salicylanilides as Inhibitors of Tubulin Polymerization and Signal Transducers and Activators of Transcription 3 (STAT3)

GARGANTILLA, Marta, Leentje PERSOONS, Tereza KAUEROVÁ, Natalia DEL RIO, Dirk DAELEMANS et. al.

Základní údaje

Originální název

Hybridization Approach to Identify Salicylanilides as Inhibitors of Tubulin Polymerization and Signal Transducers and Activators of Transcription 3 (STAT3)

Autoři

GARGANTILLA, Marta, Leentje PERSOONS, Tereza KAUEROVÁ (203 Česká republika, domácí), Natalia DEL RIO, Dirk DAELEMANS, Eva-Maria PRIEGO, Peter KOLLÁR (203 Česká republika, garant, domácí) a Maria-Jesus PEREZ-PEREZ

Vydání

Pharmaceuticals, BASEL, MDPI, 2022, 1424-8247

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.600

Kód RIV

RIV/00216224:14160/22:00126409

Organizační jednotka

Farmaceutická fakulta

UT WoS

000833255500001

Klíčová slova anglicky

tubulin polymerization inhibitors; colchicine site; salicylanilides; niclosamide; signal transducer and activator of transcription (STAT3) inhibitors

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 11. 8. 2022 07:41, JUDr. Sabina Krejčiříková

Anotace

V originále

The superimposition of the X-ray complexes of cyclohexanediones (i.e., TUB015), described by our research group, and nocodazole, within the colchicine binding site of tubulin provided an almost perfect overlap of both ligands. This structural information led us to propose hybrids of TUB015 and nocodazole using a salicylanilide core structure. Interestingly, salicylanilides, such as niclosamide, are well-established signal transducers and activators of transcription (STAT3) inhibitors with anticancer properties. Thus, different compounds with this new scaffold have been synthesized with the aim to identify compounds inhibiting tubulin polymerization and/or STAT3 signaling. As a result, we have identified new salicylanilides (6 and 16) that showed significant antiproliferative activity against a panel of cancer cells. Both compounds were able to reduce the levels of p-STAT3(Tyr705) without affecting the total expression of STAT3. While compound 6 inhibited tubulin polymerization and arrested the cell cycle of DU145 cells at G2/M, similar to TUB015, compound 16 showed a more potent effect on inhibiting STAT3 phosphorylation and arrested the cell cycle at G1/G0, similar to niclosamide. In both cases, no toxicity towards PBMC cells was detected. Thus, the salicylanilides described here represent a new class of antiproliferative agents affecting tubulin polymerization and/or STAT3 phosphorylation.